Human anti-interleukin 1α antibodies

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Immunology Letters

• Publication date

  1991-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0165-2478(91)90102-G
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti‐Interleukin‐6 Antibodies in Normal Human Serum

  1991cited by this paper
• Distribution and Characterization of Autoantibodies to Interleukin 1α in Normal Human Sera

  1990cited by this paper
• Autoantibodies to cytokines--friends or foes?

  1990cited by this paper
• Differential effects of interleukin 1α and 1β on cultured human and rat thyroid epithelial cells

  1990cited by this paper
• Demonstration of neutralizing autoantibodies against IL-1 alpha in sera from patients with rheumatoid arthritis.

  1990cited by this paper
• Autoantibodies to crude human leucocyte interferon (IFN), native human IFN, recombinant human IFN‐alpha 2b and human IFN‐gamma in healthy blood donors

  1990cited by this paper
• Interleukin 1: the first interleukin.

  1990cited by this paper
• A sensitive antiviral neutralization bioassay for measuring antibodies to interferons.

  1990cited by this paper
• Interleukin-1 and its biologically related cytokines.

  1989cited by this paper
• Native interleukin 1 inhibitors.

  1989cited by this paper
• IgG Autoantibodies against Interleukin 1α in Sera of Normal Individuals

  1989cited by this paper
• Inhibitor of Interleukin 1 in Normal Human Urine

  1988cited by this paper
• Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity.

  1988cited by this paper
• Release of multiple hormones by a direct action of interleukin-1 on pituitary cells.

  1987cited by this paper
• Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans.

  1986cited by this paper
• Immunization, Isolation of Immunoglobulins and Antibody Titre Determination

  1983cited by this paper
• The fixation of anti-HBsAg on plastic surfaces.

  1982cited by this paper

• Autoantibodies to Interferons in Infectious Diseases

  2023cites this paper
• Anticytokine autoantibodies: Autoimmunity trespassing on antimicrobial immunity.

  2022cites this paper
• Prevalence and correlation of cytokine-specific autoantibodies with epidemiological factors and C-reactive protein in 8,972 healthy individuals: Results from the Danish Blood Donor Study

  2017cites this paper
• Mining the human autoantibody repertoire: Isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma

  2014cites this paper
• Autoantibodies Against Cytokines

  2014cites this paper
• Recurrent Staphylococcal Cellulitis and Subcutaneous Abscesses in a Child with Autoantibodies against IL-61

  2008cites this paper
• Transfusion‐related inhibition of cytokines (TRICK). Experimental transfer of neutralizing autoantibodies to interleukin‐6 by plasma transfusions

  2007cites this paper
• Autoantibodies against IL-6 Subcutaneous Abscesses in a Child with Recurrent Staphylococcal Cellulitis and

  2007cites this paper
• Cytokine profiles in peripheral blood and whole blood cell cultures associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis.

  2005cites this paper
• Plasma TNF binding capacity in patients with juvenile idiopathic arthritis.

  2005cites this paper
• Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells.

  2004cites this paper
• Maturation of human dendritic cells by monocyte-conditioned medium is dependent upon trace amounts of lipopolysaccharide inducing tumour necrosis factor alpha.

  2003cites this paper
• Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor‐α and interferon‐γ, and has potential in the treatment of arthritis

  2003cites this paper
• Optimisation of the CT h4S bioassay for detection of human interleukin-4 secreted by mononuclear cells stimulated by phytohaemaglutinin or by human leukocyte antigen mismatched mixed lymphocyte culture.

  2002cites this paper
• Anti-interleukin 1α autoantibodies

  2002cites this paper
• Tumour necrosis factor‐α (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener's granulomatosis

  2001cites this paper
• Increased mRNA expression and protein secretion of interleukin‐6 in primary human osteoblasts differentiated in vitro from rheumatoid and osteoarthritic bone

  2001cites this paper
• Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts

  2000cites this paper
• Detection of autoantibodies to cytokines

  2000cites this paper
• The CC-chemokine receptor 5 (CCR5) is a marker of, but not essential for the development of human Th1 cells.

  1999cites this paper
• Administration of intravenous immunoglobulin (IVIG) in vivo—down‐regulatory effects on the IL‐1 system

  1999cites this paper
• Interleukin-10 and posttransplant lymphoproliferative disorder after kidney transplantation.

  1999cites this paper
• Studies of Interactions Between Myeloma Cells and Osteoblasts In Vitro

  1999cites this paper
• Endogenous neutralizing anti-IL-1 alpha autoantibodies in inflammatory skin diseases: possible natural inhibitor for over expressed epidermal IL-1.

  1999cites this paper
• Seasonal Variations in T-Lymphocyte Response to Grass Pollen Allergens from Pollen-Allergic Patients and Healthy Controls

  1998cites this paper
• Estrogen and Bone Loss

  1998cites this paper
• The Pysiology of Bone Turnover

  1998cites this paper
• Immunological Effects of a Hyperinsulinaemic Euglycaemic Insulin Clamp in Healthy Males

  1998cites this paper
• The peri-operative cytokine response in infants and young children following major surgery.

  1998cites this paper
• Natural and therapeutically-induced antibodies to cytokines

  1998cites this paper
• The inflammatory cytokine response after autotransfusion of shed mediastinal blood

  1998cites this paper
• Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations.

  1998cites this paper
• Increased In Vivo Antibody Activity Against Interferon α, Interleukin-1α, and Interleukin-6 After High-Dose Ig Therapy

  1997cites this paper
• The Effects of Interleukin-1 (cid:98) (IL-1 (cid:98) ) on Human Thyrocyte Functions Are Counteracted by the IL-1 Receptor Antagonist*

  1997cites this paper
• The cytokine response in a patient undergoing surgery for an ACTH‐producing tumor

  1997cites this paper
• Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra.

  1997cites this paper
• Quantitative assessment of clinical disease status in primary Sjögren's syndrome. A cross-sectional study using a new classification model.

  1997cites this paper
• High Levels of Neutralizing Autoantibodies Against IL‐1α are Associated with a Better Prognosis in Chronic Polyarthritis: a Follow‐Up Study

  1997cites this paper
• Decreased plasma levels of factor II+VII+X correlate with increased levels of soluble cytokine receptors in patients with malaria and meningococcal infections

  1997cites this paper
• The Effects of Interleukin-1β (IL-1β) on Human Thyrocyte Functions Are Counteracted by the IL-1 Receptor Antagonist.

  1997cites this paper
• Cytokines and soluble IL‐4 in patients with acute optic neuritis and multiple sclerosis

  1997cites this paper
• Immunological properties of meningococcal lipopohsaccharide from serogroups A, B & C

  1996cites this paper
• Interleukin-10 and Epstein-Barr virus-induced posttransplant lymphoproliferative disorder.

  1996cites this paper
• Anti‐Interleukin‐6 Autoantibodies in Plasma are Associated with an Increased Frequency of Infections and Increased Mortality of Patients with Alcoholic Cirrhosis

  1996cites this paper
• Increased incidence of neutralizing autoantibodies against interleukin-1α (IL-1α) in nondestructive chronic polyarthritis

  1996cites this paper
• I Components of the thesis

  1996cites this paper
• Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis

  1996cites this paper
• Membrane modifications in erythrocytes parasitized by Plasmodium falciparum.

  1996cites this paper
• In vitro cytokine production and phenotype expression by blood mononuclear cellsfrom umbilical cords, children and adults

  1996cites this paper
• Increased expression of complement receptor type 1 (CR1, CD35) on human peripheral blood T lymphocytes after polyclonal activation in vitro

  1995cites this paper
• Cytokine autoantibodies in rheumatoid arthritis.

  1995cites this paper
• Immunocytochemical localisation of interleukin-1 alpha and interleukin-6 in thyroid tissues from patients with neoplastic or autoimmune thyroid disorders.

  1995cites this paper
• IgG for intravenous use, autologous serum and plasma induce comparable interleukin-1 receptor antagonist liberation from human mononuclear cells: an in vitro phenomenon depending upon plastic adherence.

  1995cites this paper
• Cytokines and autoantibodies to cytokines

  1995cites this paper
• Cytokine production ex vivo: effect of raised body temperature.

  1995cites this paper
• Tissue culture supernatants from human islets of Langerhans activate the oxidative burst response of human monocytes in vitro.

  1995cites this paper
• Increased plasma levels of soluble IL‐2R are associated with severe Plasmodium falciparum malaria

  1994cites this paper
• Naturally Occurring Autoantibodies to Interleukin-1α, Interleukin-6, Interleukin-10, and Interferon-α

  1994cites this paper
• Sex‐ and age‐dependency of IgG auto‐antibodies against IL‐1α in healthy humans

  1994cites this paper
• Cytokines and natural regulators of cytokines.

  1994cites this paper
• Increased Concentrations ofInterleukin-6 andInterleukin-1 Receptor Antagonist andDecreased Concentrations ofBeta-2-Glycoprotein I inGambianChildren withCerebral Malaria

  1994cites this paper
• Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I.

  1993cites this paper
• High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro.

  1993cites this paper
• Effects of an Acute Bolus Growth Hormone Infusion on the Human Immune System

  1993cites this paper
• Cytokines in sputum and serum from patients with cystic fibrosis and chronic pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs.

  1993cites this paper
• In vitro immunomodulatory effects of pentoxifylline.

  1993cites this paper
• Modulation of Inflammatory Cytokines by a Receptor Antagonist, Autoantibodies, and Fever

  1993cites this paper
• Increase in lactoferrin and elastase α‐1‐proteinase inhibitor complexes but lack of complement activation and IL‐6 response following thoracic surgery

  1993cites this paper
• Effect of methylprednisolone on the cytokine response in patients undergoing lung surgery

  1993cites this paper
• Effects of human anti-IL-1 alpha autoantibodies on receptor binding and biological activities of IL-1.

  1992cites this paper
• Serum‐induced suppression of interferon (IFN) activity. Lack of evidence for the presence of specific autoantibodies to IFN‐α in normal human sera

  1992cites this paper
• Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45R0+ cells.

  1992cites this paper